Istrabenz reported consolidated earnings results for the first nine months of 2014. For the period, the company reported net loss of EUR 1.5 million ($1.9 million), from a net profit of EUR 3.8 million a year ago. Consolidated sales revenue fell to EUR 38.4 million through September from EUR 41.2 million a year ago.